490 related articles for article (PubMed ID: 16779711)
1. Impact of blood transfusions on recurrence and survival after rectal cancer surgery.
Jagoditsch M; Pozgainer P; Klingler A; Tschmelitsch J
Dis Colon Rectum; 2006 Aug; 49(8):1116-30. PubMed ID: 16779711
[TBL] [Abstract][Full Text] [Related]
2. Effect of blood transfusions on disease-free interval after rectal cancer surgery.
Chiarugi M; Buccianti P; Disarli M; Galatioto C; Cavina E
Hepatogastroenterology; 2000; 47(34):1002-5. PubMed ID: 11020864
[TBL] [Abstract][Full Text] [Related]
3. Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors.
Bufalari A; Giustozzi G; Burattini MF; Servili S; Bussotti C; Lucaroni E; Ricci E; Sciannameo F
J Surg Oncol; 2006 Mar; 93(3):173-80. PubMed ID: 16482596
[TBL] [Abstract][Full Text] [Related]
4. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results.
Melton GB; Paty PB; Boland PJ; Healey JH; Savatta SG; Casas-Ganem JE; Guillem JG; Weiser MR; Cohen AM; Minsky BD; Wong WD; Temple LK
Dis Colon Rectum; 2006 Aug; 49(8):1099-107. PubMed ID: 16779712
[TBL] [Abstract][Full Text] [Related]
5. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
Kapiteijn E; Putter H; van de Velde CJ;
Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
[TBL] [Abstract][Full Text] [Related]
6. Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer. The Swiss Group for Clinical Cancer Research (SAKK).
Eur J Surg; 1997 Sep; 163(9):693-701. PubMed ID: 9311477
[TBL] [Abstract][Full Text] [Related]
7. A model for predicting transfusion requirements in head and neck surgery.
Weber RS
Laryngoscope; 1995 Aug; 105(8 Pt 2 Suppl 73):1-17. PubMed ID: 7630307
[TBL] [Abstract][Full Text] [Related]
8. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group.
Mynster T; Christensen IJ; Moesgaard F; Nielsen HJ
Br J Surg; 2000 Nov; 87(11):1553-62. PubMed ID: 11091245
[TBL] [Abstract][Full Text] [Related]
9. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence.
van de Watering LM; Brand A; Houbiers JG; Klein Kranenbarg WM; Hermans J; van de Velde C;
Br J Surg; 2001 Feb; 88(2):267-72. PubMed ID: 11167879
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for perioperative blood transfusions in rectal resection for cancer: A multivariate analysis of a group of 212 patients.
Benoist S; Panis Y; Pannegeon V; Alves A; Valleur P
Surgery; 2001 Apr; 129(4):433-9. PubMed ID: 11283534
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic versus open surgery for rectal cancer: long-term oncologic results.
Laurent C; Leblanc F; Wütrich P; Scheffler M; Rullier E
Ann Surg; 2009 Jul; 250(1):54-61. PubMed ID: 19561481
[TBL] [Abstract][Full Text] [Related]
12. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
13. Effect of perioperative blood transfusion on prostate cancer recurrence.
Ford BS; Sharma S; Rezaishiraz H; Huben RS; Mohler JL
Urol Oncol; 2008; 26(4):364-7. PubMed ID: 18367097
[TBL] [Abstract][Full Text] [Related]
14. Blood transfusions and prognosis in colorectal cancer.
Busch OR; Hop WC; Hoynck van Papendrecht MA; Marquet RL; Jeekel J
N Engl J Med; 1993 May; 328(19):1372-6. PubMed ID: 8292113
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of perioperative blood transfusion in patients with colorectal cancer.
Jahnson S; Andersson M
Eur J Surg; 1992 Aug; 158(8):419-25. PubMed ID: 1356481
[TBL] [Abstract][Full Text] [Related]
16. Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer.
Weitz J; D'Angelica M; Gonen M; Klimstra D; Coit DG; Brennan MF; Karpeh MS
J Clin Oncol; 2003 Dec; 21(24):4597-603. PubMed ID: 14673048
[TBL] [Abstract][Full Text] [Related]
17. Comparison between the oncologic outcome of laparoscopic surgery and open surgery for T1 and T2 rectosigmoidal and rectal carcinoma: matched case-control study.
Nakamura T; Kokuba Y; Mitomi H; Onozato W; Hatate K; Satoh T; Ozawa H; Ihara A; Watanabe M
Hepatogastroenterology; 2007 Jun; 54(76):1094-7. PubMed ID: 17629046
[TBL] [Abstract][Full Text] [Related]
18. Survival advantage of using autologous blood transfusion during surgery for esophageal cancer.
Motoyama S; Saito R; Kamata S; Kitamura M; Okuyama M; Imano H; Nakamura M; Suzuki H; Omokawa S; Motohashi Y; Ogawa J
Surg Today; 2002; 32(11):951-8. PubMed ID: 12444430
[TBL] [Abstract][Full Text] [Related]
19. Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer.
Melis M; McLoughlin JM; Dean EM; Siegel EM; Weber JM; Shah N; Kelley ST; Karl RC
J Surg Res; 2009 May; 153(1):114-20. PubMed ID: 19201421
[TBL] [Abstract][Full Text] [Related]
20. Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer.
Lange MM; van Hilten JA; van de Watering LM; Bijnen BA; Roumen RM; Putter H; Brand A; van de Velde CJ;
Br J Surg; 2009 Jul; 96(7):734-40. PubMed ID: 19526613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
